aibioCosmos Health expects fourth-quarter U.S. revenue of about $15 million
Tickers COSM
Cosmos Health said active U.S. subscriptions reached 8,940 as of October 19, 2026. It expects fourth-quarter U.S. revenue of approximately $15 million and gross profit of approximately $10.5 million. The figures are preliminary and unaudited.
Key facts
- Company
- Cosmos Health Inc. (NASDAQ: COSM)
- News type
- Company Updates
- Primary source
- Cosmos Health press release (Form 8-K, Exhibit 99.1)
Cosmos Health Inc. (NASDAQ: COSM) said in a press release dated October 19, 2026 that, based on its current growth trajectory, it expects U.S. revenue of approximately $15 million for the fourth quarter of 2026, with gross profit of approximately $10.5 million. The release is included in an 8-K filed October 22, 2026. The company describes the update as a U.S. business update.
The fourth-quarter expectations
The release breaks the expected fourth-quarter U.S. revenue into components. First orders from new subscribers are expected to total approximately $8.2 million. Renewals of subscriptions started during the quarter are expected to total approximately $3.3 million. Together, subscription revenue is expected to be approximately $11.5 million. One-time purchases are expected to contribute approximately $3.5 million, for total U.S. revenue of approximately $15.0 million.
At an expected gross margin of approximately 70%, the company expects fourth-quarter U.S. gross profit of approximately $10.5 million. The outlook reflects its U.S. online direct-to-consumer business and is supported by a significantly expanded marketing budget for the fourth quarter. The company expects revenue to accelerate through the quarter, with December expected to be the strongest month.
Subscriber and order figures
As of October 19, 2026, the company's platform had tracked 14,624 U.S. online checkout orders, up 34% from the 10,881 announced on October 14, 2026. It had 8,940 active U.S. subscriptions, up 42% from 6,287 announced on October 14, 2026. Monthly subscription value at standard renewal pricing was $1,325,338, up 44% from $919,945.
The release says 65.2% of U.S. online checkout orders since the start of its subscription platform have included a subscription, up from 60.5% previously reported. In recent days, more than 85% of daily orders included a subscription. Subscribers average approximately 2.4 product units per subscription.
The company expects U.S. daily sales to rise from $60,000 at the start of the quarter to more than $200,000 by year-end. It expects active U.S. subscriptions to exceed 40,000 by year-end, more than four times current levels.
CEO Greg Siokas said: "Our U.S. business has strong momentum entering the fourth quarter, and it is building further."
Caveats in the release
The release says the subscription and order figures are as reported by the platform for its U.S. online stores. It describes them as preliminary and unaudited, and says they may differ from amounts reported in the company's financial statements. It also says monthly subscription value is an operating metric, is not a measure of revenue under U.S. GAAP and does not represent revenue earned to date.
The company
Cosmos Health Inc. was incorporated in 2009 in Nevada and describes itself as a diversified, vertically integrated global healthcare group. Its brands include Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. The 10-K says the company operates in generic medicines, nutraceuticals, biocides, medical devices, novel oncology drugs, drug repurposing and telehealth services.
Financial position
The XBRL data show revenue of $65.3 million for 2025 and $54.4 million for 2024, both from the 10-K filed April 15, 2026. Research and development expense was $519,363 for 2025 and $533,293 for 2024. The net loss was $19.1 million for 2025 and $16.2 million for 2024. Cash from operations was negative $8.4 million in 2025 and negative $7.7 million in 2024.
Year-end cash and cash equivalents were $715,674 for 2025, according to a 10-Q filed August 18, 2026, and $315,105 for 2024. The company reported cash and cash equivalents of $1.8 million as of June 30, 2026.
What the forecast leaves out
These are company projections, not results, and they rest on unaudited platform counts. The release gives no cancellation or churn figures, no customer acquisition cost and no marketing spend, though it says the outlook is supported by a significantly expanded marketing budget. The guided $15 million for one quarter compares with revenue of $65.3 million for all of 2025. The business has lost money: net loss was $19.1 million for 2025 and operating cash use was $8.4 million, while cash was $1.8 million at June 30, 2026. A forecast of more than 40,000 active subscriptions by year-end is the company's own number.